Hans Garmo

21PUBLICATIONS
38CO-AUTHORS
Predictive and prognostic markersEpidemiological modellingCancer therapy (excl. chemotherapy and radiation therapy)Epidemiological methodsEnvironmental epidemiology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (21)

|Apr 15, 2026
Temporal trends in diagnostic work-up, treatment, and mortality in locally advanced prostate cancer in 2016-2024: nationwide, population-based study in Sweden.

Armando Galdieri, Hans Garmo, Rolf Gedeborg

|Dec 26, 2025
Optimised comorbidity indices can reflect patient performance status in register based studies of prostate cancer.

Marcus Westerberg, Hans Garmo, Jesper Bonnedahl

|Dec 03, 2025
Discriminative Ability of the Charlson Comorbidity Index for Long-Term Mortality in a General Population: Nationwide, Population-Based Study of 10 Million Adults in Sweden.

Marcus Westerberg, Hans Garmo, Jonas F Ludvigsson

|Oct 13, 2025
Radium-223 use and survival by line of treatment in metastatic castration-resistant prostate cancer: a nationwide population-based register study.

Charlotte Alverbratt, Fredrik Sandin, Viktor Kolmbäck

|Jul 01, 2025
Family History of Early Onset or Lethal Prostate Cancer and the Risk of Prostate Cancer Death in Sweden.

E Lin, Hans Garmo, Kerri Beckmann

|May 16, 2025
Sociodemographic disparities in incidence rates of advanced and low-risk prostate cancer as a proxy for diagnostic activity.

Ulf Strömberg, Carl Bonander, Hans Garmo

Pageof 4

Frequent Collaborators

6 joint publications

Marcus Westerberg

6 joint publications

Pär Stattin

6 joint publications

Rolf Gedeborg

5 joint publications

Ingela Franck Lissbrant